The Immune Landscape in BCR-ABL Negative Myeloproliferative Neoplasms: Inflammation, Infections and Opportunities for Immunotherapy

Scientists focus on the immune landscape in patients with myeloproliferative neoplasms – the role of inflammation in disease pathogenesis, susceptibility to infection and emerging strategies for therapeutic immune modulation.